Pathogenesis and Management of Gonorrhea

  • Edmund C. Tramont
  • John W. Boslego
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 224)


Gonorrhea is one of the oldest recorded diseases of mankind (1). Over the past 15 years it has reached epidemic proportions, afflicting principally the most sexually active 15–30 years old age group at a rate of 12/1000/yr. The reasons for such high rates are multifactorial. Increased promiscuity among sexually active adults, the propensity of gonorrhea to remain asymptomatic, the unique epidemiology of the disease and increased antibiotic resistance have all played important roles.


Chlamydia Trachomatis Pelvic Inflammatory Disease Neisseria Gonorrhoeae Penicillin Binding Protein Gonococcal Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Preuss, J. Biblical and Talmudic Medicine (1911). F. Rosner (trans). New York. Sand hedrin Press, (1978).Google Scholar
  2. 2.
    Roseburg, T. Microbes and Morals. The Strange Story of Venereal Diseases. New York. The Viking Pess, (1971).Google Scholar
  3. 3.
    Jaffe, H.W., A.L. Schroeter, G.H. Reynolds, A.A. Zaidi, J.E. Martin and J.D. Thayer. Pharmacokinetic determinants of penicillin cure of gonococcal urethritis. Antimicrob. Ag. & Chemother. 15:587, (1979).Google Scholar
  4. 4.
    Martin, J.E., A. Lester, E.V. Price and J.D. Schamle. Comparative study of gonococcal susceptibility to penicillin in the United States, 1955–1969. J. Infect. Dis. 122:459, (1970).PubMedCrossRefGoogle Scholar
  5. 5.
    Wilson, C., D.L. Rose and E.C. Tramont. Increased antibiotic resistance of Neisseria gonorrhoeae in Korea. Antimicrob. Ag. & Chemother. 9:716, (1976).Google Scholar
  6. 6.
    Chromosomally mediated resistant Neisseria gonorrhoeae - United States. Morbid. Mortal. Week. Rep. 33:408, (1984).Google Scholar
  7. 7.
    Sparling, P.F., F.A. Sarubbi, Jr., and E. Blackman. Inheritance of low-level resistance to penicillin, tetracycline, and chloramphenicol in: Neisseria gonorrhoeae. J. Bacterid. 124:740, (1975).Google Scholar
  8. 8.
    Dougherty, T.J., A. Koller and A. Thomasz. Penicillin binding proteins of penicillin susceptible and intrinsically resistant Neisseria gonorrhoeae. Antimicrob. Ag. Chemother. 18:730, (1980).Google Scholar
  9. 9.
    Piziak, M.V., C. Woodbury, D. Berliner, E. Takafuji, J. Kirkpatrick, S. Opal and E. Tramont. Resistance trends of Neisseria gonorrheae in the Republic of Korea. Antimicrob. Ag. & Chemo. 25: 7, (1984).Google Scholar
  10. 10.
    Berg, S.W., M.E. Kilpatrick, W.O. Harrison and J.A. McCutchan. Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae. N. Engl. J. Med. 300:509, (1979).CrossRefGoogle Scholar
  11. 11.
    Ng, W.S., D.V. Chau, J. Ling, P. Echeverria, R. Rockhill and K. Arnold. Penicillinase producing N. gonorrhoeae isolates from S.E. Asia. Brit. J. Vener. Dis. 59:232, (1983).Google Scholar
  12. 12.
    Crider, S.R., S.D. Colby, L.K. Miller, W.O. Harrison, S.B.J. Kerbs and S.W. Berg. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. N. Eng. J. Med. 311:137, (1984).CrossRefGoogle Scholar
  13. 13.
    Swanson, J.S., S.J. Kraus and E.C. Gotschlich. Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns. J. Exp. Med. 134:886, (1971).PubMedCrossRefGoogle Scholar
  14. 14.
    Swanson, J. Studies of gonococcal infection. IV. Pili: their role in attachment of gonococci to tissue culture cells. J. Exp. Med. 137:571, (1973).PubMedCrossRefGoogle Scholar
  15. 15.
    Pearce, W.A. and T. Buchanan. Attachment role of gonococcal pili. J. Clin. Invest. 61:931, (1978).PubMedCrossRefGoogle Scholar
  16. 16.
    GK.Schoolnik, R. Fernandez, J.Y. Tai, J. Rothbard and E.G. Gotschlich. Gonococcal pili, primary structure and receptor binding domain. J. Exp. Med. 159:1351, (1984).PubMedCrossRefGoogle Scholar
  17. 17.
    Rothbard, J.B., R. Fernandez and GK. Schoolnik. Strain-specific and common epitopes of gonococcal pili. J. Exp. Med. 160:208, (1984).PubMedCrossRefGoogle Scholar
  18. 18.
    Boslego, J.W., R. Chung, D.M. McChesney, J. Ciak, J.S. Sadoff, M. Piziak, J. Brown, E. Tramont, C. Brinton, S. Wood and J. Bryan. Efficacy trial of a parenteral gonococcal pilus vaccine. Submitted for publication, (1985).Google Scholar
  19. 19.
    Tramont, E.G., J.W. Boslego, R. Ghung, D.M. Ghesney, J. Ciak, J. Sadoff, M. Piziak, C. Brinton, S. Wood and J. Bryan. Parenteral gonococcal pilus vaccines in pathogenesis of pathogenic Neisseria, ed G Schoolnik, Am. So. Microbiol. Washington, D.G. To be published.Google Scholar
  20. 20.
    Blake, M.S. and E.G. Gotschlich. Gonococcal membrane proteins: speculation on their role in pathogenesis. Prog. Allergy 33:258, (1983).Google Scholar
  21. 21.
    Hook, E.W., III, D.A. Olsen and T.M. Buchanan. Analysis of the antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection. Infect. Immun. 43:706, (1984).PubMedGoogle Scholar
  22. 22.
    Hechels, J.E. The surface properties of N. gonorrhoeae: isolation of the major components of the outer membrane. J. Gen. Micro. 99:333, (1977).Google Scholar
  23. 23.
    Tramont, E.G., J.G. Sadoff and C. Wilson. Variability of the lytic susceptibility of N. gonorrhoeae to human sera. J. Immun. 118:1843, (1977).PubMedGoogle Scholar
  24. 24.
    McGee, Z.A., A.P. Johnson and D. Taylor-Robinson. Pathogenic mechanisms of N. gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J. Infect. Dis. 143:413, (1981).PubMedCrossRefGoogle Scholar
  25. 25.
    Richardson, W.P. and J.G. Sadoff. Production of a capsule by Neisseria gonorrhoeae. Infect. Immun. 15:663, (1977).PubMedGoogle Scholar
  26. 26.
    Hendley, J.O., K.R. Powell, N.L. Salomonsky and R.R. Rodewald. Electron microscopy of the gonococcal capsule. J. Infect. Dis. 143:796, (1981).PubMedCrossRefGoogle Scholar
  27. 27.
    Plaut, A.G., J.V. Gilbert, M.S. Artenstein and J.D. Gapra. Neisseria gonorrhoeae and Neisseria meningitis: extracellular enzyme cleaves human immunoglobulin A. Science. 190:1103, (1975).PubMedCrossRefGoogle Scholar
  28. 28.
    Mickelson, P.A. and P.F. Sparling. Ability of N. gonorrhoeae, N. meningitis and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect. Immun. 33:555, (1981).Google Scholar
  29. 29.
    Payne, S.M., K.K. Holmes and R.A. Finkelstein. Role of iron in disseminated gonococcal infections. Infect. Immun. 20:573, (1978).PubMedGoogle Scholar
  30. 30.
    Tramont, E.G. and J. Ciak. Antigonococcal antibodies in genital secretions, Immunobiology of Neisseria gonorrhoeae, Am. Soc. Microbiol., pp 174–276, (1978).Google Scholar
  31. 31.
    Tramont, E.G. Inhibition of adherence of Neisseria gonorrhoeae by genital secretions. J. Clin. Invest. 59:117, (1977).PubMedCrossRefGoogle Scholar
  32. 32.
    Tramont, E.G., J.W. Boslego, R. Ghung, D. McChesney, J. Ciak, J. Sadoff, M. Piziak and G.G. Brinton. Gonococcal pilus vaccine in bacterial vaccines. J. Robbins ed., Thieme-Stratton. Inc., (1985).Google Scholar
  33. 33.
    Mahoney, J.F., G. Ferguson and M. Bucholtz. The use of penicillin sodium in the treatment of sulfonamide-resistant gonorrhea in men. Am. J. Syph. Gonorr. Vener. Dis. 27:525, (1943).Google Scholar
  34. 34.
    Brinton, G.G., Jr., S.W. Wood, A. Brown, A.M. Labik, J.R. Lee, S.W. Polen, E.G. Tramont, J.G. Sadoff and W.D. Zollinger. The development of a neisserial pilus vaccine for gonorrhea and meningococcal meningitis, Reviews Inf. Dis. International Symposium on Bacterial Vaccines, pg. 140, ed. Robbins, Hill, Sadoff. Thieme-Stratton, Inc., New York, (1982).Google Scholar
  35. 35.
    Westrom, L, Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequence in industrialized countries. Am. J. Obs. and Gyn. 138:880, (1980).Google Scholar
  36. 36.
    Berger, R.E., R.E. Alexander, G. Monda, J. Ansell, G. McCormick and K.K. Holmes. Chlamydia trachomatis as a cause of acute idiopathic epididymitis. N. Eng. J. Med. 298 (1978).Google Scholar
  37. 37.
    Wiesner, P.H., H.H. Handsfield and K.K. Holmes. Low antibiotic resistance of gonococci causing disseminated infection. N. Engl. J. Med. 288:1221, (1973).PubMedCrossRefGoogle Scholar
  38. 38.
    Knapp, J.S. and K.K. Holmes. Disseminated gonococcal infection caused by Neisseria gonorrhoeae with unique nutritional requirements. J. Infect. Dis. 132:204, (1975).PubMedCrossRefGoogle Scholar
  39. 39.
    Tramont, E.G., J.C. Sadoff and C. Wilson. Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera. J. Immunol. 118:1843, (1977).PubMedGoogle Scholar
  40. 40.
    Schoolnik, G.K., T.M. Buchanan and K.K. Holmes. Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J. Clin. Invest. 58:1163, (1976).PubMedCrossRefGoogle Scholar
  41. 41.
    Sexually transmitted diseases treatment guidelines 1982. Morbid. Mortal. Week. Rep. (Suppl). 31:35, (1982).Google Scholar
  42. 42.
    Stamm, W.E, M. E. Guinan, C. Johnson, S. Sturcher, K.K. Holmes and W.M. McGormack. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infections with Chlamydia trachomatis. N. Engl. J. Med. 310:545, (1984).PubMedCrossRefGoogle Scholar
  43. 43.
    Schroeter, A.L., G.H. Reynolds, K.K. Holmes, T. Pyke and P.J. Wiesner. Spectinomycin in the treatment of gonorrhea. J. Am. Vener. Dis. Ass. 1:139, (1975).Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Edmund C. Tramont
    • 1
  • John W. Boslego
    • 1
  1. 1.Department of Bacterial Diseases Division of Communicable Disease and ImmunologyWalter Reed Army Institute of ResearchUSA

Personalised recommendations